Display options
Share it on

Radiat Oncol J. 2014 Jun;32(2):77-83. doi: 10.3857/roj.2014.32.2.77. Epub 2014 Jun 30.

Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases.

Radiation oncology journal

Jun Su Park, Hee Chul Park, Doo Ho Choi, Won Park, Jeong Il Yu, Young Suk Park, Won Ki Kang, Joon Oh Park

Affiliations

  1. Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  2. Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

PMID: 25061576 PMCID: PMC4104223 DOI: 10.3857/roj.2014.32.2.77

Abstract

PURPOSE: To determine the prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases.

MATERIALS AND METHODS: Sixteen patients received whole liver radiotherapy (WLRT) between January 1997 and June 2013. A total dose of 21 Gy was delivered in 7 fractions.

RESULTS: The median survival time after WLRT was 9 weeks. In univariate analysis, performance status, serum albumin and total bilirubin level, liver volume and extrahepatic metastases were associated with survival. The mean liver volume was significantly different between subgroups with and without pain relief (3,097 and 4,739 mL, respectively; p = 0.002).

CONCLUSION: A larger liver volume is a poor prognostic factor for survival and also a negative predictive factor for response to WLRT. If patients who are referred for WLRT have large liver volume, they should be informed of the poor prognosis and should be closely observed during and after WLRT.

Keywords: Colorectal cancer; Liver; Metastasis; Radiotherapy; Tumor burden

References

  1. Radiother Oncol. 1990;18 Suppl 1:125-7 - PubMed
  2. N Engl J Med. 2004 Jun 3;350(23):2335-42 - PubMed
  3. Colorectal Dis. 2005 Mar;7(2):176-81 - PubMed
  4. Bull Acad Natl Med. 2003;187(5):815-22; discussion 822-3 - PubMed
  5. Radiother Oncol. 2002 Apr;63(1):41-5 - PubMed
  6. Int J Colorectal Dis. 2009 Sep;24(9):1097-109 - PubMed
  7. Cancer Res Treat. 2013 Mar;45(1):1-14 - PubMed
  8. N Engl J Med. 2009 Apr 2;360(14):1408-17 - PubMed
  9. Cancer. 1978 May;41(5):2013-7 - PubMed
  10. J Clin Oncol. 2000 Jan;18(1):136-47 - PubMed
  11. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):117-23 - PubMed
  12. Ann Surg. 2002 Jun;235(6):759-66 - PubMed
  13. World J Surg. 2011 Mar;35(3):684-92 - PubMed
  14. Int J Colorectal Dis. 2007 Nov;22(11):1301-10 - PubMed
  15. N Engl J Med. 2000 Sep 28;343(13):905-14 - PubMed
  16. Int J Radiat Oncol Biol Phys. 1981 May;7(5):587-91 - PubMed
  17. Arch Surg. 2008 Apr;143(4):352-8; discussion 358 - PubMed
  18. Radiat Oncol. 2010 Oct 26;5:97 - PubMed
  19. Gut. 2003 Apr;52(4):568-73 - PubMed

Publication Types